Save time and get answers to complex questions with AI chat
Novartis patent term dabrafenib?Mebendazole 100mg price?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Alogliptin benz cost?Bortezomib market france?
See the DrugPatentWatch profile for Rhopressa
Rhopressa (netarsudil ophthalmic solution) received FDA approval on December 18, 2017.
Rhopressa is used to lower intraocular pressure in people with open-angle glaucoma or ocular hypertension.
You can cross-check FDA approval and related patent/exclusivity information at DrugPatentWatch.com: https://www.drugpatentwatch.com/
Other Questions About Rhopressa :